How about Laos Adagraxibu?

Lao Adagrasib (Adagrasib), as a targeted drug, has shown significant potential in the treatment of non-small cell lung cancer carrying KRAS G12C mutations. Its unique mechanism can precisely inhibit the activity of KRAS G12C protein, thereby effectively blocking the growth and spread of tumor cells. Laos' adagrasibu belongs to the category of generic drugs. The generic drug produced by Laos Lucius Pharmaceuticals is the world's first generic adagrasibu. Its pharmaceutical ingredients are basically the same as those of the original drug. There may be differences in production specifications and prices. SpecificationsThe price of each box of 200mg*90 tablets may be more than 4,000 yuan (the price may fluctuate due to exchange rate effects).